Literature DB >> 15549564

Visual evoked potentials in migraine.

C Spreafico1, R Frigerio, P Santoro, C Ferrarese, E Agostoni.   

Abstract

Migraine is a chronic disorder. Visual symptoms and hypersensitivity to light stimuli are common. The aim of this study is the analysis of visual system in migraineurs by visual evoked potentials (VEP). We studied 53 migraineurs (21 with prophylactic migraine treatment and 32 without preventive therapy) and 20 healthy control subjects. We found lower P100 latencies in migraineurs without therapy compared to controls. In treated patients, P100 latencies showed the same trend seen in the control group. We speculate a different responsiveness of the visual system in migraineurs probably due to a dysmodulation of sensor input leading to facilitation of visual processing.

Entities:  

Mesh:

Year:  2004        PMID: 15549564     DOI: 10.1007/s10072-004-0313-5

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  5 in total

1.  Analysis of repetitive flash stimulation frequencies and record periods to detect migraine using artificial neural network.

Authors:  Selahaddin Batuhan Akben; Abdulhamit Subasi; Deniz Tuncel
Journal:  J Med Syst       Date:  2010-07-13       Impact factor: 4.460

Review 2.  Spectrum of complicated migraine in children: A common profile in aid to clinical diagnosis.

Authors:  Surya N Gupta; Vikash S Gupta; Dawn M Fields
Journal:  World J Clin Pediatr       Date:  2015-02-08

Review 3.  Visual disturbances and migraine.

Authors:  Charles E Maxner; Jeremy J Moeller
Journal:  Curr Neurol Neurosci Rep       Date:  2005-09       Impact factor: 5.081

4.  Analysis of EEG signals under flash stimulation for migraine and epileptic patients.

Authors:  Selahaddin Batuhan Akben; Abdülhamit Subasi; Deniz Tuncel
Journal:  J Med Syst       Date:  2009-10-06       Impact factor: 4.460

5.  Song listening does not affect pattern reversal visual evoked potentials.

Authors:  Raja Sawaya; Mohamed I Kanso
Journal:  Ann Saudi Med       Date:  2012 May-Jun       Impact factor: 1.526

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.